SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors

Elucidating the characteristics of human immune response against SARS-CoV-2 is of high priority and relevant for determining vaccine strategies. We report the results of a follow-up evaluation of anti-SARS-CoV-2 antibodies in 148 convalescent plasma donors who participated in a phase 2 study at a me...

Descripción completa

Detalles Bibliográficos
Autores principales: Terpos, Evangelos, Stellas, Dimitris, Rosati, Margherita, Sergentanis, Theodoros N., Hu, Xintao, Politou, Marianna, Pappa, Vassiliki, Ntanasis-Stathopoulos, Ioannis, Karaliota, Sevasti, Bear, Jenifer, Donohue, Duncan, Pagoni, Maria, Grouzi, Elisavet, Korompoki, Eleni, Pavlakis, George N., Felber, Barbara K., Dimopoulos, Meletios A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Federation of Internal Medicine. Published by Elsevier B.V. 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128693/
https://www.ncbi.nlm.nih.gov/pubmed/34053848
http://dx.doi.org/10.1016/j.ejim.2021.05.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128693/
https://www.ncbi.nlm.nih.gov/pubmed/34053848
http://dx.doi.org/10.1016/j.ejim.2021.05.010

Ejemplares similares